Overall, lncRNA-SOX2OT expression was upregulated in exosomes from NSCLC patients with BoM, and lncRNA-SOX2OT may serve as a powerful prognostic biomarker. The gene discussed is GRHL2; the disease is non-small cell lung carcinoma.